BurnsJ J, RoseR K, ChenkinT, GoldmanA, SchulertA & BrodieB B (1953) The physiological disposition of phenylbutazone (Butazolidin) in man and a method for its estimation in biological material. Journal of Pharmacology and Experimental Therapeutics109, 346
2.
DeodharS D, DickW C, HodgkinsonR & BuchananW W (1973) Measurement of clinical response to anti-inflammatory drug therapy in rheumatoid arthritis. Quarterly Journal of Medicine42, 387
3.
DickW C & GrennanD M (1976) Radio-isotopes in the study of normal and inflamed joints. Clinics in Rheumatic Diseases 2, 1, 67
4.
LeeP, AndersonJ A, MillerJ, WebbJ & BuchananW W (1976) An evaluation of the analgesic action and efficacy of anti-rheumatic drugs. A study of ten drugs in 684 patients with rheumatoid arthritis. Journal of Rheumatology 3, 3, 283
5.
OrmeM, HoltP J L, HughesG R V, BulpittC J, DraffanG H, ThorgeirssonS S, WilliamsF & DaviesD S (1974) Plasma concentration of phenylbutazone and its therapeutic effect. Studies in patients with rheumatoid arthritis. British Journal of Clinical Pharmacology3, (1), 185
6.
SiglerJ W, DuncanH, BluhmG B, EnsignD C, SharpJ T & McCrumW R (1974) Gold salts in the treatment of rheumatoid arthritis–a double-blind study. Annals of Internal Medicine80, 21
7.
BMJ1:59–60(1976) Anti-rheumatic Drugs: plenty is not enough.
